142nd Day Of Lockdown

Maharashtra54831338184318650 Tamil Nadu3145202563135278 Andhra Pradesh2641421709242378 Karnataka1964941126333511 Delhi1494601343184167 Uttar Pradesh140775887862280 West Bengal98459671202059 Telangana8647563074665 Bihar8274154139450 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3811424922127 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland30119738 Arunachal Pradesh223115923 Chandigarh1595100425 Meghalaya11154986 Sikkim9105101 Mizoram6203230
Nation Current Affairs 08 Oct 2019 Recall fails to affe ...

Recall fails to affect ranitidine

DECCAN CHRONICLE.
Published Oct 8, 2019, 1:25 am IST
Updated Oct 8, 2019, 1:25 am IST
The US Food and Drug Administration had issued a warning against the use of ranitidine, a widely prescribed antacid.
Sources in pharmaceutical industry say impurities limited to a few batches are due to a lapse in the good manufacturing process. (Representational image)
 Sources in pharmaceutical industry say impurities limited to a few batches are due to a lapse in the good manufacturing process. (Representational image)

Hyderabad: Over-the-counter sales of ranitidine remain high as it is one of the fastest-moving medicines for controlling acidity. This is despite it being recalled from the market by major pharmaceutical companies due to traces of carcinogens being found in some ranitidine samples. It is stated its distribution at the wholesale level has been stopped.

The Food and Drug Administration of US had issued a warning against the use of ranitidine, a widely prescribed antacid. Following this, the Telangana Drug Control Authority also issued an advisory against prescription of this medicine.

 

But those who have old prescriptions and regularly use ranitidine have not stopped buying this drug, as they are unaware of its harmful effects.

R. Gupta, a pharmacist said, “Ranitidine is not an over-the-counter drug. But it has become one as people use the same prescription again and again to buy the medicine.”

“It is a widely used product and has been in the market for the last 20 years. The impurity is a cause of concern. But the medicine is required by a large section of people who are suffering from acidity, diabetes and other conditions. Senior citizens also take this tablet very regularly”,” Mr Gupta said.

 

The movement of ranitidine stocks worth crores of rupees has been stopped from the depot level. But the drug is still available with retailers.

A senior drug controller said, “We are checking various batches of ranitidine. Those that have no impurity will be considered and action will be taken accordingly.”

Sources in pharmaceutical industry say impurities limited to a few batches are due to a lapse in the good manufacturing process. There is a need to have stricter checks to ensure that end products are flawless.

Another senior member of the drug control department explained, “We have been constantly getting negative inputs from Indian pharmaceutical companies. The branded generics having a good market share though there has been a sustained campaign against them in the West. As this is a very sensitive issue, we need to check and verify various batches, and that is a time-consuming process.”

 

...
Location: India, Telangana, Hyderabad




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT